Concepedia

Publication | Closed Access

Chelation therapy in patients with thalassemia using the orally active iron chelator deferiprone (L1).

59

Citations

7

References

2000

Year

Yannis Rombos, Revekka Tzanetea, K. Konstantopoulos, Spyros Simitzis, C Zervas, Manolis Kavouklis, Athanasios Aessopos, N. Sakellaropoulos, Markisia Karagiorga, Vassiliki Kalotychou
PubMed

Abstract

The results suggest that L1 is a rather safe drug which decreases iron overload without causing any considerable side-effects in Greek thalassemics.

References

YearCitations

Page 1